Graypoint LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
2,070
+55
| +3% | +$28.9K | 0.06% | 196 |
|
|
2025
Q1 | $1.28M | Sell |
2,015
-93
| -4% | -$59K | 0.08% | 167 |
|
|
2024
Q4 | $1.5M | Sell |
2,108
-238
| -10% | -$170K | 0.09% | 142 |
|
|
2024
Q3 | $2.47M | Buy |
2,346
+76
| +3% | +$79.9K | 0.16% | 106 |
|
|
2024
Q2 | $2.39M | Buy |
2,270
+136
| +6% | +$143K | 0.16% | 102 |
|
|
2024
Q1 | $2.05M | Buy |
2,134
+42
| +2% | +$40.4K | 0.15% | 112 |
|
|
2023
Q4 | $1.84M | Buy |
2,092
+47
| +2% | +$41.3K | 0.15% | 115 |
|
|
2023
Q3 | $1.68M | Sell |
2,045
-150
| -7% | -$123K | 0.16% | 114 |
|
|
2023
Q2 | $1.58M | Sell |
2,195
-225
| -9% | -$162K | 0.16% | 103 |
|
|
2023
Q1 | $1.99M | Buy |
2,420
+1,426
| +143% | +$1.17M | 0.22% | 88 |
|
|
2022
Q4 | $717K | Buy |
994
+63
| +7% | +$45.5K | 0.09% | 154 |
|
|
2022
Q3 | $641K | Buy |
931
+58
| +7% | +$39.9K | 0.08% | 163 |
|
|
2022
Q2 | $516K | Sell |
873
-35
| -4% | -$20.7K | 0.07% | 173 |
|
|
2022
Q1 | $634K | Buy |
908
+76
| +9% | +$53.1K | 0.06% | 181 |
|
|
2021
Q4 | $525K | Buy |
832
+72
| +9% | +$45.4K | 0.06% | 192 |
|
|
2021
Q3 | $460K | Buy |
760
+7
| +0.9% | +$4.24K | 0.06% | 174 |
|
|
2021
Q2 | $421K | Buy |
753
+66
| +10% | +$36.9K | 0.06% | 176 |
|
|
2021
Q1 | $325K | Buy |
687
+22
| +3% | +$10.4K | 0.05% | 180 |
|
|
2020
Q4 | $321K | Sell |
665
-22
| -3% | -$10.6K | 0.06% | 168 |
|
|
2020
Q3 | $385K | Buy |
687
+25
| +4% | +$14K | 0.07% | 141 |
|
|
2020
Q2 | $413K | Hold |
662
| – | – | 0.09% | 118 |
|
|
2020
Q1 | $323K | Buy |
+662
| New | +$323K | 0.09% | 115 |
|